Moderna Inc

$30.49
(as of Jul 3, 1:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Moderna Inc

Stock Price
$30.49
Ticker Symbol
MRNA
Exchange
NASDAQ

Industry Information for Moderna Inc

Sector
Healthcare
Industry
Biotechnology

Company Description for Moderna Inc

Country
USA
Full Time Employees
5,800

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Fundamentals for Moderna Inc

Market Capitalization
$11,095,628,800
EBITDA
$-3,536,999,936
Dividends per Share
P/E Ratio
Forward P/E Ratio
32.47
Earnings per Share
$-9.08
Earnings per Share Estimate Next Year
Profit Margin
-105.67%
Shares Outstanding
386,742,016
Percent Owned by Insiders
7.28%
Percent Owned by Institutions
73.67%
52-Week High
52-Week Low

Technical Indicators for Moderna Inc

50-Day Moving Average
200-Day Moving Average
RSI
67.79
1.41

Analyst Ratings for Moderna Inc

Strong Buy
5
Buy
1
Hold
17
Sell
3
Strong Sell
1

News About Moderna Inc

Jul 3, 2025, 1:28 PM EST
In late June 2025, Moderna underwent significant index changes, adding to the Russell Midcap indices while exiting the Russell Top 200 indices. See more.
Jul 3, 2025, 9:06 AM EST
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. See more.
Jul 2, 2025, 4:36 PM EST
Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the Oil & Gas, Basic Materials and Consumer Goods sectors led shares higher while losses in the Telecoms, Utilities and Healthcare sectors led shares lower. See more.
Jul 2, 2025, 4:33 PM EST
The RSV vaccine is now recommended for adults aged 50 to 59 who are at a high risk of severe infection. See more.